Results 101 to 110 of about 1,087 (180)

[Uterine Transplant. You are my Family Doctor and I Need your Opinion]. [PDF]

open access: yesAten Primaria
Leal Hernández M   +3 more
europepmc   +1 more source

Desconocimiento del concepto de muerte encefálica entre los inmigrantes africanos residentes en España. Análisis multivariante de factores relacionados

open access: yesNefrología
Antonio Ríos   +5 more
doaj   +1 more source

Law 2287 of 2023 on biobanks in Colombia: A bioethical reflection on its scope [PDF]

open access: yesBiomedica
Vélez-Arango JM   +3 more
europepmc   +1 more source

[Gastric Involvement in Acute Graft-Versus-Host Disease: A Case Report]. [PDF]

open access: yesActa Gastroenterol Latinoam, 2022
Chitussi M, Bajo J, Girotti C.
europepmc   +1 more source

Donor artery in coronary total occlusion recanalization: QFR versus FFR. [PDF]

open access: yesREC Interv Cardiol
Scorpiglione L   +5 more
europepmc   +1 more source

[Organ donor with PCR positive for SARS-CoV-2, it has been always no?] [PDF]

open access: yesMed Intensiva, 2022
Royo-Villanova Reparaz M   +5 more
europepmc   +1 more source

“Donantes alternativos en el trasplante alogénico de progenitores hematopoyéticos: Donante Haploidéntico vs donante no emparentado idéntico utilizando profilaxis de EICH idéntica

open access: yes
Allogeneic hematopoietic stem cell transplantation (allo- HSCT) is a consolidated treatment option in many patients with hematological malignancies. The most optimal type of transplant is from an HLA-identical related donor, which occurs in 25% of cases, which is why alternatives should be considered.
openaire   +1 more source

[The Metabolic syndrome and metabolic characteristics in blood donors] [PDF]

open access: yesRev Fac Cien Med Univ Nac Cordoba
Aro P   +7 more
europepmc   +1 more source

RDC: la perspectiva del donante

open access: yes, 2010
El compromiso de los donantes con la República Democrática del Congo es más importante que nunca, pero también es necesario que revisen sus estrategias.
openaire   +1 more source

Home - About - Disclaimer - Privacy